1,603
Views
22
CrossRef citations to date
0
Altmetric
Review Article

Immunoglobulin E (IgE) and ischemic heart disease. Which came first, the chicken or the egg?

, &
Pages 456-463 | Received 21 Mar 2014, Accepted 14 May 2014, Published online: 01 Jul 2014

References

  • Lippi G, Franchini M, Targher G. Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol. 2011;8:502–12.
  • Silvestre-Roig C, de Winther MP, Weber C, Daemen MJ, Lutgens E, Soehnlein O. Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies. Circ Res. 2014;114:214–26.
  • Chávez-Sánchez L, Espinosa-Luna JE, Chávez-Rueda K, Legorreta-Haquet MV, Montoya-Díaz E, Blanco-Favela F. Innate immune system cells in atherosclerosis. Arch Med Res. 2014;45:1–14.
  • Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12:204–12.
  • Bjorkbacka H, Fredrikson GN, Nilsson J. Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence. Atherosclerosis. 2013;227:9–17.
  • Nicolo D, Varadhachary AS, Monestier M. Atherosclerosis, antiphospholipid syndrome, and antiphospholipid antibodies. Front Biosci. 2007;12:2171–82.
  • Pate MB, Smith JK, Chi DS, Krishnaswamy G. Regulation and dysregulation of immunoglobulin E: a molecular and clinical perspective. Clin Mol Allergy. 2010;8:3.
  • Winter WE, Hardt NS, Fuhrman S. Immunoglobulin E: importance in parasitic infections and hypersensitivity responses. Arch Pathol Lab Med. 2000;124:1382–5.
  • Linneberg A. Changes in atopy over 25 years: allergy epidemic has spread to old age. BMJ. 2005;331:352.
  • Criqui MH, Lee ER, Hamburger RN, Klauber MR, Coughlin SS. IgE and cardiovascular disease. Results from a population-based study. Am J Med. 1987;82:964–8.
  • Szczeklik A, Sladek K, Szczerba A, Dropinski J. Serum immunoglobulin E response to myocardial infarction. Circulation. 1988;77:1245–9.
  • Korkmaz ME, Oto A, Saraclar Y, Oram E, Oram A, Ugurlu S, et al. Levels of IgE in the serum of patients with coronary arterial disease. Int J Cardiol. 1991;31:199–204.
  • Szczeklik A, Dropinski J, Gora PF. Serum immunoglobulin E and sudden cardiac arrest during myocardial infarction. Coron Artery Dis. 1993;4:1029–32.
  • Edston E, van Hage-Hamsten M. Immunoglobulin E, mast cell-specific tryptase and the complement system in sudden death from coronary artery thrombosis. Int J Cardiol. 1995;52:77–81.
  • Langer RD, Criqui MH, Feigelson HS, McCann TJ, Hamburger RN. IgE predicts future nonfatal myocardial infarction in men. J Clin Epidemiol. 1996;49:203–9.
  • Kovanen PT, Manttari M, Palosuo T, Manninen V, Aho K. Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. Arch Intern Med. 1998; 158:1434–9.
  • Erdogan O, Gul C, Altun A, Ozbay G. Increased immunoglobulin E response in acute coronary syndromes. Angiology. 2003;54:73–9.
  • Jong GP, Wang YF, Tsai FJ, Tsai CH, Wu CL, Liu RH, et al. Immunoglobulin E and matrix metalloproteinase-9 in patients with different stages of coronary artery diseases. Chin J Physiol. 2007;50: 277–82.
  • Sinkiewicz W, Błazejewski J, Bujak R, Kubica J, Dudziak J. Immunoglobulin E in patients with ischemic heart disease. Cardiol J. 2008; 15:122–8.
  • Wang J, Cheng X, Xiang MX, Alanne-Kinnunen M, Wang JA, Chen H, et al. IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe−/− mice. J Clin Invest. 2011;121:3564–77.
  • Baalash AA, Hamouda HE, Ismail GM, Yassein IK, Ibrahim BM. The role of heat shock protein 70, IgE and MMP-9 in detecting early minor myocardial damage and evaluating the efficacy of coronary artery bypass grafting (CABG). J Life Sci. 2012;6:260–7.
  • Jaramillo R, Cohn RD, Crockett PW, Gowdy KM, Zeldin DC, Fessler MB. Relation between objective measures of atopy and myocardial infarction in the United States. J Allergy Clin Immunol. 2013;131:405–11.
  • Shiue I. Are higher serum IgE concentrations associated with adult cardiovascular disease?Int J Cardiol. 2013;168:1580–1.
  • Kovcic J, Nurkic J, Nurkic M. C-reactive protein, immunoglobuline E and natural killer cells in patients with coronary artery disease. J Am Coll Cardiol. 2013;62:C203.
  • Linneberg A, Jacobsen RK, Jespersen L, Abildstrom SZ. Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality. J Allergy Clin Immunol. 2012;129:413–19.
  • Yong PF, Freeman AF, Engelhardt KR, Holland S, Puck JM, Grimbacher B. An update on the hyper-IgE syndromes. Arthritis Res Ther. 2012;14:228.
  • Hilfiker-Kleiner D, Hilfiker A, Fuchs M, Kaminski K, Schaefer A, Schieffer B, et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res. 2004;95:187–95.
  • Ling JC, Freeman AF, Gharib AM, Arai AE, Lederman RJ, Rosing DR, et al. Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. Clin Immunol. 2007;122:255–8.
  • Young TY, Jerome D, Gupta S. Hyperimmunoglobulinemia E syndrome associated with coronary artery aneurysms: deficiency of central memory CD4 + T cells and expansion of effector memory CD4 + T cells. Ann Allergy Asthma Immunol. 2007;98:389–92.
  • Gharib AM, Pettigrew RI, Elagha A, Hsu A, Welch P, Holland SM, et al. Coronary abnormalities in hyper-IgE recurrent infection syndrome: depiction at coronary MDCT angiography. AJR Am J Roentgenol. 2009;193:W478–81.
  • Freeman AF, Avila EM, Shaw PA, Davis J, Hsu AP, Welch P, et al. Coronary artery abnormalities in Hyper-IgE syndrome. J Clin Immunol. 2011;31:338–45.
  • Bot I, Biessen EA. Mast cells in atherosclerosis. Thromb Haemost. 2011;106:820–6.
  • Kounis NG, Giannopoulos S, Goudevenos J. Beware of, not only the dogs, but the passionate kissing and the Kounis syndrome. J Cardiovasc Med (Hagerstown). 2011;12:149–50.
  • Kounis NG, Zavras GM. Histamine-induced coronary artery spasm: the concept of allergic angina. Br J Clin Pract. 1991;45:121–8.
  • Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm?Int J Cardiol. 2006;110: 7–14.
  • Potaczek DP. Links between allergy and cardiovascular or hemostatic system. Int J Cardiol. 2014;170:278–85.
  • Kovanen PT. Mast cells: multipotent local effector cells in atherothrombosis. Immunol Rev. 2007;217:105–22.
  • Kinoshita M, Okada M, Hara M, Furukawa Y, Matsumori A. Mast cell tryptase in mast cell granules enhances MCP-1 and interleukin-8 production in human endothelial cells. Arterioscler Thromb Vasc Biol. 2005;25:1858–63.
  • Kokkonen JO, Kovanen PT. Low-density-lipoprotein binding by mast-cell granules. Demonstration of binding of apolipoprotein B to heparin proteoglycan of exocytosed granules. Biochem J. 1987; 241:583–9.
  • Ma H, Kovanen PT. IgE-dependent generation of foam cells: an immune mechanism involving degranulation of sensitized mast cells with resultant uptake of LDL by macrophages. Arterioscler Thromb Vasc Biol. 1995;15:811–19.
  • Ma H, Kovanen PT. Inhibition of mast cell-dependent conversion of cultured macrophages into foam cells with antiallergic drugs. Arterioscler Thromb Vasc Biol. 2000;20:E134–42.
  • Pinckard RN, Tanigawa C, Halonen M. IgE-induced blood coagulation alterations in the rabbit: consumption of coagulation factors XII, XI, and IX in vivo. J Immunol. 1975;115:525–32.
  • Steffel J, Akhmedov A, Greutert H, Luscher TF, Tanner FC. Histamine induces tissue factor expression: implications for acute coronary syndromes. Circulation. 2005;112:341–9.
  • Sinkiewicz W, Blazejewski J, Bujak R, Zekanowska E, Sobański P, Kubica J, et al. Immunoglobulin E as a marker of the atherothrombotic process in patients with acute myocardial infarction. Cardiol J. 2007;14:266–73.
  • Swedenborg J, Mäyränpää MI, Kovanen PT. Mast cells: important players in the orchestrated pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2011;31:734–40.
  • Achatz G, Achatz-Straussberger G, Feichtner S, Koenigsberger S, Lenz S, Peckl-Schmid D, et al. The biology of IgE: molecular mechanism restraining potentially dangerous high serum IgE titres in vivo. In: Penichet ML, Jensen-Jarolim E, editors. Cancer and IgE: introducing the concept of allergooncology. New York, NY: Humana Press, Inc.; 2010; pp. 13–36.
  • Binder CJ, Witztum JL. Is atherosclerosis an allergic disease?Circ Res. 2011;109:1103–4.
  • Ebert CS Jr, Pillsbury HC 3rd.Epidemiology of allergy. Otolaryngol Clin North Am. 2011;44:537–548, vii.
  • Law M, Morris JK, Wald N, Luczynska C, Burney P. Changes in atopy over a quarter of a century, based on cross sectional data at three time periods. BMJ. 2005;330:1187–8.
  • Sirot V, Leblanc JC, Margaritis I. A risk-benefit analysis approach to seafood intake to determine optimal consumption. Br J Nutr. 2012;107:1812–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.